358 related articles for article (PubMed ID: 28009985)
1. Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis.
Gao Y; Zhang K; Xi H; Cai A; Wu X; Cui J; Li J; Qiao Z; Wei B; Chen L
Oncotarget; 2017 Jan; 8(4):6330-6340. PubMed ID: 28009985
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysis.
Creemers A; Krausz S; Strijker M; van der Wel MJ; Soer EC; Reinten RJ; Besselink MG; Wilmink JW; van de Vijver MJ; van Noesel CJM; Verheij J; Meijer SL; Dijk F; Bijlsma MF; van Oijen MGH; van Laarhoven HWM
Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):394-403. PubMed ID: 28801248
[TBL] [Abstract][Full Text] [Related]
3. Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer.
Yang J; Gong Y; Lam VK; Shi Y; Guan Y; Zhang Y; Ji L; Chen Y; Zhao Y; Qian F; Chen J; Li P; Zhang F; Wang J; Zhang X; Yang L; Kopetz S; Futreal PA; Zhang J; Yi X; Xia X; Yu P
Cell Death Dis; 2020 May; 11(5):346. PubMed ID: 32393783
[TBL] [Abstract][Full Text] [Related]
4. Clinical Value of ctDNA in Hematological Malignancies (Lymphomas, Multiple Myeloma, Myelodysplastic Syndrome, and Leukemia): A Meta-Analysis.
Tan X; Yan H; Chen L; Zhang Y; Sun C
Front Oncol; 2021; 11():632910. PubMed ID: 33747954
[No Abstract] [Full Text] [Related]
5. Utilizing circulating tumour DNA as a prognostic predictor of gastric cancer: a meta-analysis.
Min L; Chen J; Yu M; Yang K; Liu D
Biomarkers; 2023 Dec; 28(5):427-436. PubMed ID: 37036017
[No Abstract] [Full Text] [Related]
6. Circulating tumor DNA is effective for detection of KRAS mutation in colorectal cancer: a meta-analysis.
Tang M; Deng Z; Li B; Peng Y; Song M; Liu J
Int J Biol Markers; 2017 Oct; 32(4):e421-e427. PubMed ID: 28885658
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor DNA
Sun X; Li H; Sun M; Yuan Y; Sun L
Future Oncol; 2019 Oct; 15(30):3513-3525. PubMed ID: 31578881
[No Abstract] [Full Text] [Related]
8. Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis.
Cullinane C; Fleming C; O'Leary DP; Hassan F; Kelly L; O'Sullivan MJ; Corrigan MA; Redmond HP
JAMA Netw Open; 2020 Nov; 3(11):e2026921. PubMed ID: 33211112
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis.
Fang Z; Meng Q; Zhang B; Shi S; Liu J; Liang C; Hua J; Yu X; Xu J; Wang W
Aging (Albany NY); 2020 Dec; 13(2):2031-2048. PubMed ID: 33318293
[TBL] [Abstract][Full Text] [Related]
10. Serum Helicobacter pylori KatA and AhpC antibodies as novel biomarkers for gastric cancer.
Zhang B; Li HL; Fan Q; Guo F; Ren XY; Zhou HB; Zhu JW; Zhao YS; Tian WJ
World J Gastroenterol; 2016 Jun; 22(21):5060-7. PubMed ID: 27275098
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
12. Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis.
Dai M; Yuan F; Fu C; Shen G; Hu S; Shen G
PLoS One; 2017; 12(4):e0175357. PubMed ID: 28403178
[TBL] [Abstract][Full Text] [Related]
13. Methylation status of TRAF2 is associated with the diagnosis and prognosis of gastric cancer.
Zhang J; Dai WJ; Yang XZ
Int J Clin Exp Pathol; 2015; 8(11):14228-34. PubMed ID: 26823737
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumour DNA-Based molecular residual disease detection in resectable cancers: a systematic review and meta-analysis.
Zheng J; Qin C; Wang Q; Tian D; Chen Z
EBioMedicine; 2024 May; 103():105109. PubMed ID: 38614009
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of circulating tumor DNA in localized non-small cell lung cancer: a systematic review and meta-analysis.
Guo RQ; Peng JZ; Sun J; Li YM
Clin Exp Med; 2023 Sep; 23(5):1621-1631. PubMed ID: 36315311
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor DNA is effective for the detection of EGFR mutation in non-small cell lung cancer: a meta-analysis.
Qiu M; Wang J; Xu Y; Ding X; Li M; Jiang F; Xu L; Yin R
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):206-12. PubMed ID: 25339418
[TBL] [Abstract][Full Text] [Related]
17. In Silico screening of circulating tumor DNA, circulating microRNAs, and long non-coding RNAs as diagnostic molecular biomarkers in ovarian cancer: A comprehensive meta-analysis.
Zhang L; Hu C; Huang Z; Li Z; Zhang Q; He Y
PLoS One; 2021; 16(4):e0250717. PubMed ID: 33901236
[TBL] [Abstract][Full Text] [Related]
18. RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients.
Yao J; Zang W; Ge Y; Weygant N; Yu P; Li L; Rao G; Jiang Z; Yan R; He L; Yu Y; Jin M; Cheng G; An G
Can J Gastroenterol Hepatol; 2018; 2018():4248971. PubMed ID: 29707525
[TBL] [Abstract][Full Text] [Related]
19. High expression of CD11c indicates favorable prognosis in patients with gastric cancer.
Wang Y; Xu B; Hu WW; Chen LJ; Wu CP; Lu BF; Shen YP; Jiang JT
World J Gastroenterol; 2015 Aug; 21(31):9403-12. PubMed ID: 26309367
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Silencing of the MLH1 Promoter in Relation to the Development of Gastric Cancer and its use as a Biomarker for Patients with Microsatellite Instability: a Systematic Analysis.
Hu G; Qin L; Zhang X; Ye G; Huang T
Cell Physiol Biochem; 2018; 45(1):148-162. PubMed ID: 29334683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]